Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

TransMedics Group, Inc. (TMDX)

69.07   2.94 (4.45%) 01-27 16:00
Open: 66.13 Pre. Close: 66.13
High: 69.08 Low: 66.02
Volume: 305,475 Market Cap: 2,205(M)

Technical analysis

as of: 2023-01-27 4:48:34 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 80.68     One year: 94.24
Support: Support1: 59.34    Support2: 53.33
Resistance: Resistance1: 69.08    Resistance2: 80.68
Pivot: 62.13
Moving Average: MA(5): 67.13     MA(20): 60.99
MA(100): 53.57     MA(250): 38.88
MACD: MACD(12,26): 2.5     Signal(9): 1.6
Stochastic oscillator: %K(14,3): 91     %D(3): 90.6
RSI: RSI(14): 66.3
52-week: High: 69.08  Low: 10
Average Vol(K): 3-Month: 367 (K)  10-Days: 373 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ TMDX ] has closed below upper band by 12.4%. Bollinger Bands are 66.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 69.11 - 69.46 69.46 - 69.8
Low: 65.24 - 65.58 65.58 - 65.93
Close: 68.5 - 69.06 69.06 - 69.63

Company Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Headline News

Sun, 29 Jan 2023
Quantbot Technologies LP Makes New Investment in TransMedics ... - MarketBeat

Wed, 25 Jan 2023
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Truist ... - MarketBeat

Tue, 24 Jan 2023
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating ... - MarketBeat

Thu, 19 Jan 2023
12500 Shares in TransMedics Group, Inc. (NASDAQ:TMDX ... - MarketBeat

Mon, 16 Jan 2023
Is TransMedics Group (NASDAQ:TMDX) A Risky Investment? - Simply Wall St

Mon, 09 Jan 2023
3 Breakout Growth Stocks to Buy for the Long Haul - The Motley Fool

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 32 (M)
Shares Float 31 (M)
% Held by Insiders 3.8 (%)
% Held by Institutions 94.3 (%)
Shares Short 1,530 (K)
Shares Short P.Month 2,120 (K)

Stock Financials

EPS -1.7
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.88
Profit Margin (%) -58.8
Operating Margin (%) -50.2
Return on Assets (ttm) -11.1
Return on Equity (ttm) -31.7
Qtrly Rev. Growth 378.2
Gross Profit (p.s.) 0.66
Sales Per Share 2.24
EBITDA (p.s.) -1.05
Qtrly Earnings Growth 0
Operating Cash Flow -48 (M)
Levered Free Cash Flow -45 (M)

Stock Valuations

PE Ratio -40.87
PEG Ratio 0
Price to Book value 11.74
Price to Sales 30.72
Price to Cash Flow -45.53

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.